Live from the NIH registry
Studies recruiting near Springfield right now
Top 25 of 151 recruiting studies, sorted by proximity — each links to its official registry page
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: NRG Oncology
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 1
Interventional 24 participants sought
Red River Research Partners — Bolivar, Missouri (29.8 mi)
· Sponsor: Incyte Corporation
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Breast Cancer, TNBC - Triple-Negative Breast Cancer
N/A
Observational 900 participants sought
Oncology Hematology Associates — Springfield, Missouri (1.5 mi)
· Sponsor: Tempus AI
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Oncology Hematology Associates — Springfield, Missouri (1.5 mi)
· Sponsor: Eli Lilly and Company
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
N/A
Observational 5,000 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: National Cancer Institute LAO
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: SWOG Cancer Research Network
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity, Overweight
Phase 3
Interventional 400 participants sought
Clinvest Research — Springfield, Missouri (1.5 mi)
· Sponsor: Novo Nordisk A/S
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Springfield, Missouri (1.5 mi)
· Sponsor: GlaxoSmithKline
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
CoxHealth South Hospital — Springfield, Missouri (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Mercy Research — Springfield, Missouri (1.5 mi)
· Sponsor: Novo Nordisk A/S
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Cox Health — Springfield, Missouri (1.5 mi)
· Sponsor: Paradigm Health
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Red River Research Partners, Llc- Site Number : 8400054 — Bolivar, Missouri (29.8 mi)
· Sponsor: Sanofi
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: SWOG Cancer Research Network
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Phase 3
Interventional 336 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Springfield, Missouri (1.5 mi)
· Sponsor: Axsome Therapeutics, Inc.
A Study of V132 in Healthy Older Participants (V132-001)
Healthy
Phase 1
Interventional 280 participants sought
Bio-Kinetic Clinical Applications, LLC dba QPS-MO ( Site 0002) — Springfield, Missouri (1.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: NRG Oncology
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
Phase 3
Interventional 303 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma
N/A
Observational 800 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: University of Rochester
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
Multiple Myeloma
Phase 2
Interventional 200 participants sought
GSK Investigational Site — Springfield, Missouri (1.5 mi)
· Sponsor: GlaxoSmithKline
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Acute Treatment of Migraine
Phase 3
Interventional 600 participants sought
Clinvest Research, LLC — Springfield, Missouri (1.5 mi)
· Sponsor: Pfizer
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
AAA - Abdominal Aortic Aneurysm
N/A
Observational 2,000 participants sought
Cox Health — Springfield, Missouri (1.5 mi)
· Sponsor: W.L.Gore & Associates
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Non-small Cell Lung Cancer
Phase 3
Interventional 600 participants sought
Cox Medical Center North ( Site 0133) — Springfield, Missouri (1.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology